3-Methyl-4-chlorophenol for prion decontamination of medical devices

Infection Control and Hospital Epidemiology

Volumn 27, Issue 7, 2006, Pages 778-780

  Riemer, Constanze ^a   Bamme, Theresa ^a   Mok, Simon Wing Fai ^a   Baier, Michael ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROCRESOL; CHLOROPHENOL; HYDROXYBIPHENYL; HYPOCHLORITE SODIUM; PHENOL DERIVATIVE; PRION PROTEIN; PROTEINASE K; SODIUM HYDROXIDE;

ARTICLE; BRAIN HOMOGENATE; BRAIN SPONGIOSIS; DEVICE INFECTION; DISINFECTION; HAMSTER; INFECTION; INFECTION CONTROL; INOCULATION; MEDICAL INSTRUMENTATION; NONHUMAN; PRION; PRION DISEASE; RISK REDUCTION; SCRAPIE;

BLOTTING, WESTERN; CHLOROPHENOLS; DISINFECTANTS; EQUIPMENT AND SUPPLIES; PRIONS;

EID: 33747697724     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/504450     Document Type: Article

References (15)

1. Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 2000; 159:10-17.
2. Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowicz T, Gajdusek DC, Gibbs CJ Jr. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977; 1:478-479.
3. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999; 353:693-697.
4. Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001; 358:171-180.
5. Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003; 349:1812-1820.
6. Jackson GS, McKintosh E, Flechsig E, et al. An enzyme-detergent method for effective prion decontamination of surgical steel. J Gen Virol 2005; 86:869-878.
7. Race RE, Raymond GJ. Inactivation of transmissible spongiform encephalopathy (prion) agents by environ LpH. J Virol 2004; 78:2164-2165.
8. Baier M, Schwarz A, Mielke M. Activity of an alkaline "cleaner" in the inactivation of the scrapie agent. J Hosp Infect 2004; 57:80-84.
9. Baier M, Norley S, Schultz J, Burwinkel M, Schwarz A, Riemer C. Prion diseases: infectious and lethal doses following oral challenge. J Gen Virol 2003; 84:1927-1929.
10. McKinley MP, Bolton DC, Prusiner SB. A protease-resistant protein is a structural component of the scrapie prion. Cell 1983; 35:57-62.
11. Fichet G, Comoy E, Duval C, et al. Novel methods for disinfection of prion-contaminated medical devices. Lancet 2004; 364:521-526.
12. Baxter HC, Campbell GA, Whittaker AG, et al. Elimination of transmissible spongiform encephalopathy infectivity and decontamination of surgical instruments by using radio-frequency gas-plasma treatment. J Gen Virol 2005; 86:2393-2399.
13. Bertram J, Mielke M, Beekes M, Lemmer K, Baier M, Pauli G. Inactivation and removal of prions in producing medical products: a contribution to evaluation and declaration of possible methods [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2004; 47:36-38.
14. Yan Z-X, Stitz L, Heeg P, Pfaff E, Roth K. Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol 2004; 25:280-283.
15. Organisation for Economic Co-operation and Development (OECD) guidelines for testing of chemicals. Ready biodegradability assay: modified Sturm test. OECD no. 301 B. Paris: OECD; 1981.